[HTML][HTML] The Banff 2015 kidney meeting report: current challenges in rejection classification and prospects for adopting molecular pathology
The XIII Banff meeting, held in conjunction the Canadian Society of Transplantation in
Vancouver, Canada, reviewed the clinical impact of updates of C4d-negative antibody-
mediated rejection (ABMR) from the 2013 meeting, reports from active Banff Working
Groups, the relationships of donor-specific antibody tests (anti-HLA and non-HLA) with
transplant histopathology, and questions of molecular transplant diagnostics. The use of
transcriptome gene sets, their resultant diagnostic classifiers, or common key genes to …
Vancouver, Canada, reviewed the clinical impact of updates of C4d-negative antibody-
mediated rejection (ABMR) from the 2013 meeting, reports from active Banff Working
Groups, the relationships of donor-specific antibody tests (anti-HLA and non-HLA) with
transplant histopathology, and questions of molecular transplant diagnostics. The use of
transcriptome gene sets, their resultant diagnostic classifiers, or common key genes to …